News & Articles

The all-new rapifleX™ extends MALDI leadership in protein characterization, biologics development and QC, as well as in Mass Spectrometry Imaging (MSI)

Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS

First Prospective Clinical Trial of Liquid Biopsy with Real-World Clinical Application

Studies demonstrate pioneering research possible using ChIP technology

34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting

Collaboration with Therawis addresses unmet need to guide clinical decisions in breast cancer

AMSBIO’s new MitoXpress® Intra offers high throughput analysis of intracellular oxygen

New Phenome Centre Birmingham to use Thermo Scientific mass spectrometry instruments to advance metabolic phenotyping and metabolomics studies

Learn how digital PCR is advancing cancer genetics research at Louisiana State University Health Sciences Center

Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics

Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples

Top tips to optimize your analyses

Vitrification provides excellent survivability of embryos and oocytes through the freezing process

Detects biomarkers of horse infection, inflammation, immune response and general health

Interlab comparison demonstrates Circulogene’s blood-drop-volume liquid biopsy assay is fastest, most accurate process to date for tracking and treating cancer

BioTek Instruments, Inc. presented with Scientists' Choice Award® at AACR

Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis

Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System

MassHunter VistaFlux will help cancer researchers better understand metabolic pathways

RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses